An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer

Abstract EN

Background.

In the past few years, the immune system and tumor immune microenvironment are becoming increasingly popular as more work has been accomplished in this field.

However, nomograms based on immune-related characteristics for prognosis prediction of cervical cancer have not been fully explored to our knowledge.

We constructed a novel immune score-based nomogram to predict patients with high risk and poor prognosis.

Materials and Methods.

198 patients with cervical cancer from The Cancer Genome Atlas (TCGA) database were included in our study.

Immune scores were generated with Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm, and clinic-pathological characteristics were also included for subsequent analysis.

Cox proportional hazards regression models were performed for univariate and multivariate analyses to screen the significant factors, and a prognostic nomogram was built.

Bootstrap resampling analysis was used for internal validation.

The calibration curve and concordance index (C-index) were used to assess the predictive performance of the nomogram.

Results.

Patients were split into three subgroups based on immune scores.

We found that patients with high immune scores conferred significantly better overall survival (OS) compared with those with medium and low immune scores (hazard ratio (HR), 0.305; 95% confidence interval (CI), 0.108-0.869).

A nomogram with a C-index of 0.720 had a favorable performance for predicting survival rate for clinical use by combining immune scores with other clinical features.

The calibration curves at 3 and 5 years suggested a good consistency between the predicted OS and the actual OS probability.

Conclusions.

Our work highlights the potential clinical application significance of immune score-based nomogram in predicting the OS of cervical cancer patients.